A detailed history of Castleark Management LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 19,260 shares of RYTM stock, worth $1.08 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
19,260
Previous 19,010 1.32%
Holding current value
$1.08 Million
Previous $780,000 29.36%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.81 - $55.0 $10,202 - $13,750
250 Added 1.32%
19,260 $1.01 Million
Q2 2024

Aug 13, 2024

SELL
$35.41 - $44.37 $1.59 Million - $1.99 Million
-44,890 Reduced 70.25%
19,010 $780,000
Q1 2024

May 15, 2024

BUY
$39.12 - $52.44 $2.5 Million - $3.35 Million
63,900 New
63,900 $2.77 Million

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.13B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.